|
TWI329105B
(en)
*
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
|
ES2445208T3
(es)
|
2002-07-29 |
2014-02-28 |
Rigel Pharmaceuticals, Inc. |
Compuestos de 2,4-pirimidindiamina para uso en métodos para tratar o prevenir enfermedades autoinmunitarias
|
|
PT1656372E
(pt)
|
2003-07-30 |
2013-06-27 |
Rigel Pharmaceuticals Inc |
Métodos para o tratamento ou prevenção de doenças autoimunes com compostos de 2,4-pirimidinadiamina
|
|
SG146683A1
(en)
*
|
2003-09-17 |
2008-10-30 |
Janssen Pharmaceutica Nv |
Fused heterocyclic compounds as serotonin receptor modulators
|
|
AU2011253635B2
(en)
*
|
2003-09-17 |
2014-10-30 |
Janssen Pharmaceutica, N.V. |
Fused heterocyclic compounds
|
|
AU2004313947B2
(en)
*
|
2003-12-17 |
2011-03-31 |
Sgx Pharmaceuticals, Inc. |
Bicyclic pyrazolo-fused compounds as protein kinase modulators
|
|
WO2005123111A2
(en)
*
|
2004-06-21 |
2005-12-29 |
Exelixis, Inc. |
Maxs as modifiers of the axin pathway and methods of use
|
|
AU2005286592A1
(en)
|
2004-09-23 |
2006-03-30 |
Reddy Us Therapeutics, Inc. |
Novel pyrimidine compounds, process for their preparation and compositions containing them
|
|
AU2006206458B2
(en)
|
2005-01-19 |
2012-10-25 |
Rigel Pharmaceuticals, Inc. |
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
|
|
US20070203161A1
(en)
*
|
2006-02-24 |
2007-08-30 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
|
NZ563454A
(en)
|
2005-06-08 |
2011-03-31 |
Rigel Pharmaceuticals Inc |
2,4-diaminopyrimidine derivatives for inhibition of the JAK pathway
|
|
WO2007098507A2
(en)
|
2006-02-24 |
2007-08-30 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
|
CA2650140A1
(en)
|
2006-04-14 |
2007-10-25 |
Mriganka Sur |
Identifying and modulating molecular pathways that mediate nervous system plasticity
|
|
AR061974A1
(es)
*
|
2006-07-14 |
2008-08-10 |
Novartis Ag |
Derivados de pirimidina como inhibidores de alk, composiciones farmaceuticas y procesos de obtencion
|
|
MX2009004771A
(es)
*
|
2006-11-01 |
2009-06-17 |
Vertex Pharma |
Compuestos heteroaril triciclicos utiles como inhibidores de janus cinasa.
|
|
US20100204231A1
(en)
*
|
2007-05-04 |
2010-08-12 |
Astrazeneca Ab |
Amino-thiazolyl-pyrimidine derivatives and their use for the treatment of cancer
|
|
HRP20170317T1
(hr)
|
2008-02-15 |
2017-04-21 |
Rigel Pharmaceuticals, Inc. |
Spojevi pirimidin-2-amina i njihova uporaba kao inhibitora jak kinaza
|
|
US8138339B2
(en)
|
2008-04-16 |
2012-03-20 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
|
AU2009244897B2
(en)
|
2008-04-16 |
2014-11-13 |
Alexion Pharmaceuticals, Inc. |
2, 6-diamino- pyrimidin- 5-yl-carboxamides as syk or JAK kinases inhibitors
|
|
US8258144B2
(en)
*
|
2008-04-22 |
2012-09-04 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
|
JP5063815B2
(ja)
*
|
2008-11-25 |
2012-10-31 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
抗腫瘍および抗神経変性剤としての二環式ピラゾールおよびイソオキサゾール誘導体
|
|
CA2752150A1
(en)
*
|
2009-02-11 |
2010-08-19 |
Reaction Biology Corp. |
Selective kinase inhibitors
|
|
US8663210B2
(en)
|
2009-05-13 |
2014-03-04 |
Novian Health, Inc. |
Methods and apparatus for performing interstitial laser therapy and interstitial brachytherapy
|
|
JO3030B1
(ar)
*
|
2009-06-26 |
2016-09-05 |
Galapagos Nv |
مركب جديد مفيد لمعالجة الامراض التنكسية والالتهابات
|
|
EP2454257B1
(en)
*
|
2009-07-15 |
2013-08-21 |
AbbVie Inc. |
Pyrrolopyridine inhibitors of kinases
|
|
EP2459195A1
(en)
*
|
2009-07-28 |
2012-06-06 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
|
WO2011025947A1
(en)
*
|
2009-08-28 |
2011-03-03 |
Array Biopharma Inc. |
Raf inhibitor compounds and methods of use thereof
|
|
UY33213A
(es)
*
|
2010-02-18 |
2011-09-30 |
Almirall Sa |
Derivados de pirazol como inhibidores de jak
|
|
EP2635557A2
(en)
|
2010-11-01 |
2013-09-11 |
Portola Pharmaceuticals, Inc. |
Nicotinamides as jak kinase modulators
|
|
US9198911B2
(en)
|
2010-11-02 |
2015-12-01 |
The Trustees Of Columbia University In The City Of New York |
Methods for treating hair loss disorders
|
|
CA2856301C
(en)
|
2011-11-23 |
2020-10-06 |
Portola Pharmaceuticals, Inc. |
Pyrazine kinase inhibitors
|
|
WO2013113762A1
(en)
|
2012-01-31 |
2013-08-08 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and kits for predicting the risk of having a cutaneous melanoma in a subject
|
|
DK2830662T3
(da)
*
|
2012-03-29 |
2019-01-02 |
Univ Columbia |
Fremgangsmåder til behandlng af hårtabsforstyrrelser
|
|
IN2014KN02601A
(cg-RX-API-DMAC7.html)
|
2012-04-24 |
2015-05-08 |
Vertex Pharma |
|
|
WO2014013014A1
(en)
|
2012-07-18 |
2014-01-23 |
Fundació Privada Centre De Regulació Genòmica (Crg) |
Jak inhibitors for activation of epidermal stem cell populations
|
|
US9676756B2
(en)
|
2012-10-08 |
2017-06-13 |
Portola Pharmaceuticals, Inc. |
Substituted pyrimidinyl kinase inhibitors
|
|
ES2711839T3
(es)
|
2013-03-12 |
2019-05-07 |
Vertex Pharma |
Inhibidores de DNA-PK
|
|
MX361488B
(es)
|
2013-10-17 |
2018-12-07 |
Vertex Pharma |
Cocristales de (s)-n-metil-8-(1-((2'-metil-[4,5'-bipirimidin]-6-il ) amino)propan-2-il)quinolina-4-carboxamida y sus derivados deuterados como inhibidores de proteínas cinasa dependientes de adn (adn-pk).
|
|
EP3489232A3
(en)
*
|
2014-04-04 |
2019-07-31 |
Syros Pharmaceuticals, Inc. |
Inhibitors of cyclin-dependent kinase 7 (cdk7)
|
|
JP6713465B2
(ja)
*
|
2014-12-30 |
2020-06-24 |
ノヴィラ・セラピューティクス・インコーポレイテッド |
Ｂ型肝炎感染症治療のための誘導体及び方法
|
|
CN108472298B
(zh)
|
2015-11-24 |
2021-04-20 |
深圳阿拉丁医疗科技有限公司 |
选择性激酶抑制剂
|
|
WO2018041989A1
(en)
|
2016-09-02 |
2018-03-08 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for diagnosing and treating refractory celiac disease type 2
|
|
AU2017335648B2
(en)
|
2016-09-27 |
2022-02-17 |
Vertex Pharmaceuticals Incorporated |
Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors
|
|
US10759865B2
(en)
|
2017-08-22 |
2020-09-01 |
Eyal Levit |
Treatment of diabetes mellitus
|
|
US20200199136A1
(en)
*
|
2017-08-28 |
2020-06-25 |
Acurastem Inc. |
Pikfyve kinase inhibitors
|
|
CN108586341B
(zh)
*
|
2018-05-25 |
2020-05-08 |
天津商业大学 |
酰胺类化合物和其药用盐及其制备方法和药物用途
|
|
BR112021018168B1
(pt)
|
2019-03-21 |
2023-11-28 |
Onxeo |
Composição farmacêutica, combinação e kit compreendendo uma molécula dbait e um inibidor de quinase para o tratamento de câncer
|
|
EP3947737A2
(en)
|
2019-04-02 |
2022-02-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods of predicting and preventing cancer in patients having premalignant lesions
|
|
US20220202820A1
(en)
|
2019-04-16 |
2022-06-30 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of jak inhibitors for the treatment of painful conditions involving nav1.7 channels
|
|
KR20220098759A
(ko)
|
2019-11-08 |
2022-07-12 |
인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) |
키나제 억제제에 대해 내성을 획득한 암의 치료 방법
|
|
WO2021148581A1
(en)
|
2020-01-22 |
2021-07-29 |
Onxeo |
Novel dbait molecule and its use
|
|
CN114605390B
(zh)
*
|
2020-12-04 |
2024-08-16 |
上海凌达生物医药有限公司 |
具有cdk激酶抑制活性的化合物、其药物组合物和用途
|
|
IL308314A
(en)
|
2021-05-07 |
2024-01-01 |
Kymera Therapeutics Inc |
CDK2 compounds and their uses
|
|
EP4526469A1
(en)
|
2022-05-16 |
2025-03-26 |
Institut National de la Santé et de la Recherche Médicale |
Methods for assessing the exhaustion of hematopoietic stems cells induced by chronic inflammation
|